VFG
V2 Financial group’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $216K | Hold |
3,300
| – | – | 0.13% | 78 |
|
2025
Q1 | $233K | Hold |
3,300
| – | – | 0.15% | 74 |
|
2024
Q4 | $217K | Hold |
3,300
| – | – | 0.13% | 78 |
|
2024
Q3 | $233K | Hold |
3,300
| – | – | 0.15% | 69 |
|
2024
Q2 | $227K | Hold |
3,300
| – | – | 0.15% | 69 |
|
2024
Q1 | $224K | Buy |
3,300
+2,200
| +200% | +$149K | 0.15% | 64 |
|
2023
Q4 | $204K | Buy |
+1,100
| New | +$204K | 0.14% | 63 |
|
2023
Q1 | – | Sell |
-1,100
| Closed | -$205K | – | 61 |
|
2022
Q4 | $205K | Buy |
+1,100
| New | +$205K | 0.16% | 60 |
|
2022
Q3 | – | Sell |
-1,100
| Closed | -$211K | – | 59 |
|
2022
Q2 | $211K | Hold |
1,100
| – | – | 0.17% | 56 |
|
2022
Q1 | $214K | Hold |
1,100
| – | – | 0.16% | 58 |
|
2021
Q4 | $220K | Hold |
1,100
| – | – | 0.17% | 65 |
|
2021
Q3 | $201K | Hold |
1,100
| – | – | 0.17% | 60 |
|
2021
Q2 | $204K | Buy |
+1,100
| New | +$204K | 0.17% | 58 |
|